Rainmed Medical Limited (HK:2297) has released an update.
Rainmed Medical Limited reported a significant drop in revenue and gross profit for the first half of 2024, with revenues decreasing by 46.6% and gross profit by 49.9% compared to the previous year. The company also recorded a loss attributable to shareholders of RMB 41.6 million, although this reflects a 12.4% improvement from the previous year’s loss. No interim dividend will be declared as the firm continues to invest in research and development, manufacturing, and commercialization of medical instruments.
For further insights into HK:2297 stock, check out TipRanks’ Stock Analysis page.